Figure 1
![Time to event curves for patients in the phase 2 DRC study. (A) Overall survival (OS) according to age (≤65, 66 to 75, and 75 years). (B) WM-related and unrelated mortality. (C) OS per response category (including very good partial response [VGPR] category as per the revised response criteria published by Owen et al1). (D) Progression, and unrelated mortality without progression. CR, complete response; MR, minor response.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/126/11/10.1182_blood-2015-05-647420/4/1392f1.jpeg?Expires=1720811174&Signature=Hh-~RbrufgOm-yWVXQzzihUNwEExD~Hpki9z-ZldPN1msgePUh04cshP5VVmLu9Rdd2m-Wlkr8XK7C7A36pDjs3SiB~8JiN7HUi~cCQX9Vy0RPZNdXSRvTtFvDDsoW1ik346dRDmj~-0FSPgdk2j3YjoGSs3ujpgRXde6VjvzcmwM8jigl46jWPnq2NLgj9Y92X0zTVQLTA6qWbfMfvT57erd7XYM-srUD~EppbuP7g367i5MeSO~jXocfTpcshwg6vU3CJ5G~OrMLuaL-6tdg4fwd2Q9f4kyouik50~oOHwf5pVPEBSZNhAiosbfp3pzRfbaOGzBUnwm2UiX9PdFw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time to event curves for patients in the phase 2 DRC study. (A) Overall survival (OS) according to age (≤65, 66 to 75, and 75 years). (B) WM-related and unrelated mortality. (C) OS per response category (including very good partial response [VGPR] category as per the revised response criteria published by Owen et al1 ). (D) Progression, and unrelated mortality without progression. CR, complete response; MR, minor response.
